Affordable Access

deepdyve-link
Publisher Website

Successful use of methylprednisolone for treating severe COVID-19.

Authors
  • Liu, Jing1
  • Zheng, Xiaobin2
  • Huang, Yiying2
  • Shan, Hong3
  • Huang, Jin4
  • 1 Department of Pulmonary and Critical Care Medicine, The Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, China; Guangdong Provincial Key Laboratory of Biomedical Imaging and Guangdong Provincial Engineering Research Center of Molecular Imaging, The Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, China. , (China)
  • 2 Department of Pulmonary and Critical Care Medicine, The Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, China. , (China)
  • 3 Guangdong Provincial Key Laboratory of Biomedical Imaging and Guangdong Provincial Engineering Research Center of Molecular Imaging, The Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, China; Department of Radiology, The Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, China. Electronic address: [email protected] , (China)
  • 4 Department of Pulmonary and Critical Care Medicine, The Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, China; Guangdong Provincial Key Laboratory of Biomedical Imaging and Guangdong Provincial Engineering Research Center of Molecular Imaging, The Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, China. Electronic address: [email protected] , (China)
Type
Published Article
Journal
The Journal of allergy and clinical immunology
Publication Date
May 29, 2020
Identifiers
DOI: 10.1016/j.jaci.2020.05.021
PMID: 32479759
Source
Medline
Keywords
Language
English
License
Unknown

Abstract

Timely and appropriate application of methylprednisolone in severe and critical COVID-19 patients could effectively avoid invasive mechanical ventilation and reduce the mortality. Copyright © 2020. Published by Elsevier Inc.

Report this publication

Statistics

Seen <100 times